The delta opioid receptor: a novel therapeutic target for pain and even more ...

被引：0
|
作者：
Gaveriaux-Ruff, C. [1 ]
机构：
[1] Univ Strasbourg, Dept Neurobiol & Genet, INSERM, IGBMC,CNRS,UMR7104,U964, F-67400 Illkirch Graffenstaden, France
来源：
DOULEUR ET ANALGESIE | 2009年 / 22卷 / 04期
关键词：
Opioid receptor; Delta; Chronic pain; Anxiety depression; ANTIDEPRESSANT-LIKE ACTIVITIES; PROTEIN-COUPLED RECEPTORS; RAT MODEL; AGONIST SNC80; NEUROPATHIC PAIN; FUNCTIONAL COMPETENCE; ANTINOCICEPTIVE PROPERTIES; CHRONIC INFLAMMATION; MORPHINE-TOLERANCE; RHESUS-MONKEYS;
D O I：
10.1007/s11724-009-0146-3
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
The delta opioid receptor is a novel target for pain treatment. The delta receptor appears different from the mu receptor as it is poorly effective for acute nociception but becomes more active in pathological situations. The interest for this receptor has increased recently with the identification of novel ligands and the study of its intracellular traffic. In addition, delta receptor activation lowers anxiety and depression. This review presents the recent knowledge on delta opioid analgesia and on the other neurobiological effects of delta receptor activation.
引用
收藏
页码：201 / 209
页数：9
相关论文
共 50 条
  • [21] Neuropathic Pain Unmasks Delta Opioid Receptor-Mediated Analgesia
    Ong, Edmund W.
    Holdridge, Sarah V.
    Sutherland, Karen Anne
    Armstrong, Stacey A.
    Taylor, Anna M. W.
    Xue, Lihua
    Cahill, Catherine M.
    FASEB JOURNAL, 2016, 30
  • [22] Sigma 1 receptor: A new therapeutic target for pain
    Zamanillo, Daniel
    Romero, Luz
    Merlos, Manuel
    Miguel Vela, Jose
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 716 (1-3) : 78 - 93
  • [23] A G-protein-biased delta opioid receptor (DOPr) agonist with improved therapeutic profile for use in in chronic pain
    Conibear, A. E.
    Asghar, J.
    Helyes, S.
    Borbely, E.
    Kendall, D.
    von Mentzer, B.
    Kelly, E.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (16) : 3048 - 3049
  • [24] Mu opioid receptor in endometriosis: A potential novel target for the treatment in endometriosis-associated pain.
    Matsuzaki, S
    Canis, M
    Pouly, J
    Rabischong, B
    Botchorischvili, R
    Mage, G
    FERTILITY AND STERILITY, 2005, 84 : S122 - S122
  • [25] Novel Targets of Delta Opioid-Receptor for RGC Neuroprotection
    Husain, Shahid
    Ahmad, Anis
    Singh, Sudha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [26] A Novel Approach to Safer Analgesics: Mu Opioid Receptor Agonist & Delta Opioid Receptor Antagonist Peptidomimetics
    Fernandez, Thomas Joaquin
    Griggs, Nicholas
    Nastase, Anthony
    Anand, Jessica
    Jutkiewicz, Emily J.
    Mosberg, Henry
    Traynor, John
    FASEB JOURNAL, 2018, 32 (01):
  • [27] Design and synthesis of novel delta opioid receptor agonists and their pharmacologies
    Nagase, Hiroshi
    Osa, Yumiko
    Nemoto, Toru
    Fujii, Hideaki
    Imai, Masayuki
    Nakamura, Takashi
    Kanemasa, Toshiyuki
    Kato, Akira
    Gouda, Hiroaki
    Hirono, Shuichi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) : 2792 - 2795
  • [28] Binding characteristics of novel delta receptor selective opioid peptides
    Borsodi, A
    Spetea, M
    Szatmari, I
    Darula, ZS
    Kertész, I
    Tóth, G
    FASEB JOURNAL, 1997, 11 (09): : A1050 - A1050
  • [29] Liver X Receptor: A Novel Therapeutic Target
    Patel, M. B.
    Oza, N. A.
    Anand, I. S.
    Deshpande, S. S.
    Patel, C. N.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 70 (02) : 135 - 144
  • [30] Estrogen Receptor β Is a Novel Therapeutic Target for Photoaging
    Chang, Ken C. N.
    Wang, Yihe
    Oh, Inn Gyung
    Jenkins, Susan
    Freedman, Leonard P.
    Thompson, Catherine C.
    Chung, Jin Ho
    Nagpal, Sunil
    MOLECULAR PHARMACOLOGY, 2010, 77 (05) : 744 - 750
12345